ReposiTrak (TRAK) Q4 FY26 earnings call

ReposiTrak delivered strong profitability in Q4 FY26, driven by a strategic shift towards predictable recurring SaaS revenue and improved operating cost structures. The company launched its new 'touchless merchandising' initiative, a significant market opportunity addressing DSD segment pain points, and expects it to be a meaningful contributor in 2027 and beyond. Traceability revenue is also anticipated to accelerate as the FDA's 2028 compliance deadline approaches, further solidifying the company's market position.